Showing 1241-1250 of 3810 results for "".
Planning a Comeback
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/planning-a-comeback/23300/CSF Faculty members open up about how COVID-19 impacted their practices and what they did about it.Advancements in Care for Skin of Color
https://practicaldermatology.com/topics/skin-of-color/advancements-in-care-for-skin-of-color/22989/From patient education to novel therapeutics, there are promising new approaches to patient care.Currents: Beautiful Choices
https://practicaldermatology.com/topics/practice-management/currents-8/23794/New Products/New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-otc-5/23159/About Face: Longer Shifts for Residents; Residents of Distinction Honored; Ask an Expert: Managing PIH
https://practicaldermatology.com/youngmd-connect/resident-resource-center/about-face-longer-shifts-for-residents-residents-of-distinction-honored-ask-an-expert-managing-pih/20716/It’s No Skin Off My Nose: How Celebrity Influencers Use Social Media to Affect Behavior
https://practicaldermatology.com/youngmd-connect/resident-resource-center/its-no-skin-off-my-nose-how-celebrity-influencers-use-social-media-to-affect-behavior/23539/Be prepared to recognize and respond to social media trends.Getting a Head Start on Skin Cancer
https://practicaldermatology.com/topics/practice-management/getting-a-head-start-on-skin-cancer/23422/A new app documents monthly skin changes to support early identification of suspicious lesions.Soliton’s RAP Technology for Cellulite
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/solitons-rap-technology-for-cellulite/23465/An inside look at the latest device designed to target cellulite.Currents
https://practicaldermatology.com/topics/practice-management/currents/21127/Compounding Update: New Developments Offer Hope
https://practicaldermatology.com/topics/skin-cancer-photoprotection/compounding-update-new-developments-offer-hope/20318/Recent draft guidance from the FDA suggests dermatologists may escape burdensome federal regulation.